http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095564-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
filingDate 2013-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11910dc6a8717b92a377f947348854b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed1635f341609c0cab65f8536687f770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e13d8a5ae74205b65983374c9a20de6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96bad56dec89946b519c769c4a850e29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee49ba75fdf8e7936079a1a8584539d6
publicationDate 2015-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9095564-B2
titleOfInvention von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
abstract The present invention relates to a von Willebrand Factor for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes. Furthermore, the present invention relates to a method of treating and/or preventing a disorder related to a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes comprising administering a pharmaceutically effective amount of a von-Willebrand-Factor (vWF) to a patient in need thereof. The present invention also relates to a composition comprising vWF and a composition comprising FVIII for simultaneous, separate or sequential use for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9878017-B2
priorityDate 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2156991-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003125250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212042-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4430205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0713881-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002062492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9729753-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5364430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18395083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9861403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226949026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127712924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 65.